SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER

DesmondN. Carney, DanielC Ihde, MartinH Cohen, +4

The Lancet

Tumor InnervationMedicinePathologyBronchial NeoplasmLung Cancer +5

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.

Austin Doyle, Martin Wj, Keiko Funa, +7

The Journal of Experimental Medicine

ImmunologyHistocompatibility AntigensPathologyImmunoeditingImmunotherapy +17

Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

Dennis J. Ahnen, Polly Feigl, G. Quan, +7

PubMed

Tumor BiologyKi-ras MutationCancer EpidemiologyMedicineP53 Expression +13

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo, +12

Annals of Oncology

OncologyProtein ExpressionMedicinePathologyCancer Genomics +4

Small Cell Carcinoma Presenting as an Extrapulmonary Neoplasm: Sites of Origin and Response to Chemotherapy<xref ref-type="fn" rid="fn2">2</xref>

Robert M. Levenson, D C Ihde, Mary J. Matthews, +4

JNCI Journal of the National Cancer Institute

Adjuvant ChemotherapyPathologySurgeryTumor BiologyOncology +17

Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.

Andrea J. Cohen, P A Bunn, Wilbur A. Franklin, +7

PubMed

Lung InflammationImmunologyPathologyNsclc TumorsPeptide Science +20

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.

Elise C. Kohn, Ronald G. Steis, E. A. Sausville, +7

Journal of Clinical Oncology

ImmunodeficienciesImmunologyPathologyBiological TherapyPharmacotherapy +15

Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma.

Jorge A. Carrasquillo, James L. Mulshine, P A Bunn, +7

PubMed

Cutaneous T-cell LymphomaLymphoid NeoplasiaIodine-131 T101MedicineHistopathology +13

A Phase II Multicenter Study of CAMPATH-1H Antibody in Previously Treated Patients with Nonbulky Non-Hodgkin's Lymphoma

Alok A. Khorana, P A Bunn, Peter McLaughlin, +3

Leukemia & lymphoma/Leukemia and lymphoma

Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC)

Nasser H. Hanna, L. Einhorn, A. Sandler, +7

Journal of Clinical Oncology

Ip Vs EpEs SclcPharmacotherapyNeuro-oncologyOncology +14